An experimental workflow for enrichment of low abundant proteins from human serum for the discovery of serum biomarkers
TL;DR: In this paper , the authors presented a robust, reproducible and cost-effective experimental workflow to remove immunoglobulins and albumin from serum with high efficiency, which enabled identification of 681 low abundance proteins that were otherwise undetectable in the serum.
read more
Abstract: Serum contains proteins that possess important information about diseases and their progression. Unfortunately, these proteins, which carry the information in the serum are in low abundance and are masked by other serum proteins that are in high abundance. Such masking prevents their identification and quantification. Therefore, removal of high abundance proteins is required to enrich, identify, and quantify the low abundance proteins. Immunodepletion methods are often used for this purpose, but there are limitations in their use because of off-target effects and high costs. Here we presented a robust, reproducible and cost-effective experimental workflow to remove immunoglobulins and albumin from serum with high efficiency. The workflow did not suffer from such limitations and enabled identification of 681 low abundance proteins that were otherwise undetectable in the serum. The identified low abundance proteins belonged to 21 different protein classes, namely the immunity-related proteins, modulators of protein-binding activity, and protein-modifying enzymes. They also played roles in various metabolic events, such as integrin signalling, inflammation-mediated signalling, and cadherin signalling. The presented workflow can be adapted to remove abundant proteins from other types of biological material and to provide considerable enrichment for low-abundance proteins.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Mass Spectrometry-Based Proteomic Technology and Its Application to Study Skeletal Muscle Cell Biology.
Paul Dowling,Dieter Swandulla,Kay Ohlendieck +2 more
TL;DR: The main bioanalytical avenues taken in the proteomic characterization of skeletal muscle tissues are outlined, including top-down proteomics focusing on the characterization of intact proteoforms and their post-translational modifications, bottom-up proteomics, which is a peptide-centric method concerned with the large-scale detection of proteins in complex mixtures, and subproteomics that examines the protein composition of distinct subcellular fractions.
6
Differential Protease Specificity by Collagenase as a Novel Approach to Serum Proteomics That Includes Identification of Extracellular Matrix Proteins without Enrichment.
Jade K Macdonald,Cassandra L. Clift,Janet E. Saunders,Stephen Zambrzycki,Anand Mehta,Richard R. Drake,Peggi M. Angel +6 more
TL;DR: The potential for serum biomarker research using differential protease specificity (DPS) using alternate protease specificity as a targeting mechanism to selectively digest circulating ECM protein serum proteins is investigated.
2
Proteomics As A Valid Tool In Biomarker Discovery For Alzheimer's Disease
Valeria Magnelli
- 22 Jan 2024
TL;DR: Proteomics is a valid tool for biomarker discovery in Alzheimer's disease, offering the potential for early diagnosis and monitoring of the disease.
2
Comparative Analysis of Digestion Methods for Bile Proteomics: The Key to Unlocking Biliary Biomarker Potential
Adam M. Thorne,Mirthe Hoekzema,Robert J. Porte,Folkert Kuipers,Vincent E. de Meijer,Justina C. Wolters +5 more
TL;DR: This study compares six trypsin digestion methods for bile proteomics, finding that methods involving precipitation outperform crude methods, with in-gel digestion being an efficient and simple option for bile proteomics analysis.
Quantitative proteomic and glycoproteomic analysis identifies CLCA1, FBN1, and FGB as potential biomarkers for ulcerative colitis
Xiaotong Wang,Siyue Bo,Qin-Kai Li,Wentong Li,Longjiang Xu,Duanmin Hu,Shuang Yang,Xiaotong Wang,Siyue Bo,Qin-Kai Li,Wentong Li,Longjiang Xu,Duanmin Hu,Shuang Yang +13 more
TL;DR: Quantitative proteomic and glycoproteomic analysis identifies CLCA1, FBN1, and FGB as potential biomarkers for ulcerative colitis, a prevalent inflammatory bowel disease with increased risk of colorectal cancer.
References
The Human Plasma Proteome History, Character, and Diagnostic Prospects
TL;DR: This work speculates on the reasons behind this large discrepancy between the expectations arising from proteomics and the realities of clinical diagnostics and suggests approaches by which protein-disease associations may be more effectively translated into diagnostic tools in the future.
4.4K
Genomic atlas of the human plasma proteome.
Benjamin B. Sun,Joseph C. Maranville,James E. Peters,James E. Peters,David Stacey,James R Staley,James A. Blackshaw,Stephen Burgess,Tao Jiang,Ellie Paige,Ellie Paige,Praveen Surendran,Clare Oliver-Williams,Mihir A Kamat,Bram P. Prins,Sheri K. Wilcox,Erik S Zimmerman,An Chi,Narinder Bansal,Narinder Bansal,Sarah L. Spain,Angela M. Wood,Nicholas W. Morrell,Nicholas W. Morrell,John Bradley,Nebojsa Janjic,David J. Roberts,David J. Roberts,Willem H. Ouwehand,John A. Todd,Nicole Soranzo,Karsten Suhre,Dirk S. Paul,Caroline S. Fox,Robert M. Plenge,John Danesh,John Danesh,Heiko Runz,Adam S. Butterworth +38 more
TL;DR: The genetic architecture of the human plasma proteome in healthy blood donors from the INTERVAL study is characterized, and it is shown that protein quantitative trait loci overlap with gene expression quantitative traits, as well as with disease-associated loci, and evidence that protein biomarkers have causal roles in disease is found.
Human body fluid proteome analysis
TL;DR: The proteomics technologies currently used for global identification and quantification of body fluid proteins are summarized, and the putative biomarkers discovered for a variety of human diseases through human body fluid proteome (HBFP) analysis are elaborate.
Depletion of abundant plasma proteins and limitations of plasma proteomics.
Chengjian Tu,Paul A. Rudnick,Misti Y. Martinez,Kristin L. Cheek,Stephen E. Stein,Robbert J.C. Slebos,Daniel C. Liebler +6 more
TL;DR: The effects of top 7/top 14 immunodepletion on the shotgun proteomic analysis of human plasma was evaluated and it was found that either top 7 or top 14 immunoaffinity depletion resulted in a 25% increase in identified proteins compared to unfractionated plasma.
Differences among techniques for high-abundant protein depletion.
Nina Zolotarjova,James Martosella,Gordon Nicol,Jerome Bailey,Barry E. Boyes,William C. Barrett +5 more
TL;DR: The current work addresses some of the potential problems in depleting proteins in typical biomarker studies, including nonspecific binding during depletion procedures and whether low molecular weight species bind to the column in a so‐called “sponge” effect.
301